Quick Answer
Imunon, Inc. reported Operating Income Loss of -$14.65 million for the year ending 2025.
- Imunon, Inc. showed an increase of +23.4% in Operating Income Loss from 2024 to 2025.
- This data is from Imunon, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: -$4.46 million | Q3 2010: -$5.17 million | Q1 2011: -$3.56 million | Q2 2011: -$6.25 million | Q3 2011: -$6.82 million | Q1 2012: -$6.26 million | Q2 2012: -$5.71 million | Q3 2012: -$4.96 million | Q1 2013: -$4.77 million | Q2 2013: -$3.85 million | Q3 2013: -$3.53 million | Q1 2014: -$5.20 million | Q2 2014: -$6.41 million | Q3 2014: -$6.67 million | Q1 2015: -$6.41 million | Q2 2015: -$5.24 million | Q3 2015: -$4.24 million | Q1 2016: -$5.18 million | Q2 2016: -$4.74 million | Q3 2016: -$5.60 million | Q1 2017: -$4.82 million | Q2 2017: -$4.40 million | Q3 2017: -$4.40 million | Q1 2018: -$4.28 million | Q2 2018: -$8.01 million | Q3 2018: -$4.02 million | Q1 2019: -$4.86 million | Q2 2019: -$5.57 million | Q3 2019: -$5.39 million | Q1 2020: -$4.77 million | Q2 2020: -$4.77 million | Q3 2020: -$4.16 million | Q1 2021: -$5.38 million | Q2 2021: -$5.07 million | Q3 2021: -$5.06 million | Q1 2022: -$5.84 million | Q2 2022: -$5.98 million | Q3 2022: -$6.17 million | Q1 2023: -$5.68 million | Q2 2023: -$5.47 million | Q3 2023: -$3.90 million | Q1 2024: -$5.01 million | Q2 2024: -$5.01 million | Q3 2024: -$4.96 million | Q1 2025: -$4.15 million | Q2 2025: -$2.77 million | Q3 2025: -$3.48 million.
- Over the full 16 years of available data (2010 to 2025), Imunon, Inc.'s Operating Income Loss has grown by 25.4%.
- Historical annual values: Fiscal year 2025: -$14.65 million | Fiscal year 2024: -$19.13 million | Fiscal year 2023: -$21.03 million | Fiscal year 2022: -$24.92 million | Fiscal year 2021: -$21.01 million | Fiscal year 2020: -$18.49 million | Fiscal year 2019: -$20.57 million | Fiscal year 2018: -$21.07 million | Fiscal year 2017: -$18.47 million | Fiscal year 2016: -$20.65 million | Fiscal year 2015: -$20.85 million | Fiscal year 2014: -$24.72 million | Fiscal year 2013: -$15.41 million | Fiscal year 2012: -$22.14 million | Fiscal year 2011: -$23.02 million | Fiscal year 2010: -$19.64 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: